Literature DB >> 26820959

Patient-Derived Tumor Xenograft Models of Breast Cancer.

Christopher D Suarez1, Laurie E Littlepage2.   

Abstract

The need for model systems that more accurately predict patient outcome has led to a renewed interest and a rapid development of orthotopic transplantation models designed to grow, expand, and study patient-derived human breast tumor tissue in mice. After implanting a human breast tumor piece into a mouse mammary fat pad and allowing the tumor to grow in vivo, the tumor tissue can be either harvested and immediately implanted into mice or can be stored as tissue pieces in liquid nitrogen for surgical implantation at a later time. Here, we describe the process of surgically implanting patient-derived breast tumor tissue into the mammary gland of nonobese diabetic-severe combined immunodeficiency (NOD-SCID) mice and harvesting tumor tissue for long-term storage in liquid nitrogen.

Entities:  

Keywords:  Breast cancer; Orthotopic transplant; Patient-derived tumor xenograft

Mesh:

Substances:

Year:  2016        PMID: 26820959     DOI: 10.1007/978-1-4939-3444-7_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Efficacy of radiation exposure in laryngeal squamous cell carcinoma is mediated by the LAMP3/LAMC2/tenascin-C pathway.

Authors:  Hao Wu; Juanjuan Li; Jianqiu Chen; Yong Yin; Peng Da; Qingwen Chen; Zhenxin Zhang; Jinxing Wang; Guohua Wang; Xiaoxia Qiu
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-07

2.  Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts.

Authors:  Maiko Okano; Masanori Oshi; Ali Butash; Ichiro Okano; Katsuharu Saito; Tsutomu Kawaguchi; Masayuki Nagahashi; Koji Kono; Toru Ohtake; Kazuaki Takabe
Journal:  J Mammary Gland Biol Neoplasia       Date:  2020-02-27       Impact factor: 2.673

3.  Preclinical Therapeutic Assessment of a New Chemotherapeutics [Dichloro(4,4'-Bis(2,2,3,3-Tetrafluoropropoxy) Methyl)-2,2'-Bipryridine) Platinum] in an Orthotopic Patient-Derived Xenograft Model of Triple-Negative Breast Cancers.

Authors:  Tzu-Chun Kan; Mei-Hsiang Lin; Chun-Chia Cheng; Jeng-Wei Lu; Ming-Thau Sheu; Yuan-Soon Ho; Sri Rahayu; Jungshan Chang
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

4.  Phototheranostics of CD44-positive cell populations in triple negative breast cancer.

Authors:  Jiefu Jin; Balaji Krishnamachary; Yelena Mironchik; Hisataka Kobayashi; Zaver M Bhujwalla
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

5.  The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance.

Authors:  Christopher D Suarez; Junmin Wu; Sunil S Badve; Joseph A Sparano; William Kaliney; Laurie E Littlepage
Journal:  Oncotarget       Date:  2017-07-17

6.  Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma.

Authors:  Dan Su; Dadong Zhang; Jiaoyue Jin; Lisha Ying; Miao Han; Kaiyan Chen; Bin Li; Junzhou Wu; Zhenghua Xie; Fanrong Zhang; Yihui Lin; Guoping Cheng; Jing-Yu Li; Minran Huang; Jinchao Wang; Kailai Wang; Jianjun Zhang; Fugen Li; Lei Xiong; Andrew Futreal; Weimin Mao
Journal:  Nat Commun       Date:  2019-11-07       Impact factor: 14.919

7.  Establishment of a stable hepatic metastasis mouse model of murine colorectal cancer by microsurgical orthotopic implantation.

Authors:  Zhiyun Cao; Zhideng Zhang; Liangpu Zheng; Jiumao Lin; Jun Peng; Wei Lin
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.